169 related articles for article (PubMed ID: 19493466)
1. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
[TBL] [Abstract][Full Text] [Related]
2. CD4 and CD8 T cell responses to tumour-associated Epstein-Barr virus antigens in nasopharyngeal carcinoma patients.
Lin X; Gudgeon NH; Hui EP; Jia H; Qun X; Taylor GS; Barnardo MC; Lin CK; Rickinson AB; Chan AT
Cancer Immunol Immunother; 2008 Jul; 57(7):963-75. PubMed ID: 18094968
[TBL] [Abstract][Full Text] [Related]
3. Dual stimulation of Epstein-Barr Virus (EBV)-specific CD4+- and CD8+-T-cell responses by a chimeric antigen construct: potential therapeutic vaccine for EBV-positive nasopharyngeal carcinoma.
Taylor GS; Haigh TA; Gudgeon NH; Phelps RJ; Lee SP; Steven NM; Rickinson AB
J Virol; 2004 Jan; 78(2):768-78. PubMed ID: 14694109
[TBL] [Abstract][Full Text] [Related]
4. Plasma Epstein-Barr virus DNA and risk of nasopharyngeal carcinoma in a prospective seropositive population.
Chen WJ; Xu WN; Wang HY; Chen XX; Li XQ; Xie SH; Lin DF; Cao SM
BMC Cancer; 2021 Jun; 21(1):651. PubMed ID: 34074258
[TBL] [Abstract][Full Text] [Related]
5. Two-step Epstein-Barr virus immunoglobulin A enzyme-linked immunosorbent assay system for serological screening and confirmation of nasopharyngeal carcinoma.
Paramita DK; Fachiroh J; Haryana SM; Middeldorp JM
Clin Vaccine Immunol; 2009 May; 16(5):706-11. PubMed ID: 19321695
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of measuring Epstein-Barr virus (EBV) DNA load and carcinoma-specific viral mRNA in relation to anti-EBV immunoglobulin A (IgA) and IgG antibody levels in blood of nasopharyngeal carcinoma patients from Indonesia.
Stevens SJ; Verkuijlen SA; Hariwiyanto B; Harijadi ; Fachiroh J; Paramita DK; Tan IB; Haryana SM; Middeldorp JM
J Clin Microbiol; 2005 Jul; 43(7):3066-73. PubMed ID: 16002393
[TBL] [Abstract][Full Text] [Related]
7. Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins.
Bollard CM; Gottschalk S; Torrano V; Diouf O; Ku S; Hazrat Y; Carrum G; Ramos C; Fayad L; Shpall EJ; Pro B; Liu H; Wu MF; Lee D; Sheehan AM; Zu Y; Gee AP; Brenner MK; Heslop HE; Rooney CM
J Clin Oncol; 2014 Mar; 32(8):798-808. PubMed ID: 24344220
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cells transduced with an adenovirus vector encoding Epstein-Barr virus latent membrane protein 2B: a new modality for vaccination.
Ranieri E; Herr W; Gambotto A; Olson W; Rowe D; Robbins PD; Kierstead LS; Watkins SC; Gesualdo L; Storkus WJ
J Virol; 1999 Dec; 73(12):10416-25. PubMed ID: 10559360
[TBL] [Abstract][Full Text] [Related]
9. Acquisition of polyfunctionality by Epstein-Barr virus-specific CD8+ T cells correlates with increased resistance to galectin-1-mediated suppression.
Smith C; Beagley L; Khanna R
J Virol; 2009 Jun; 83(12):6192-8. PubMed ID: 19357166
[TBL] [Abstract][Full Text] [Related]
10. Deficient EBV-specific B- and T-cell response in patients with chronic fatigue syndrome.
Loebel M; Strohschein K; Giannini C; Koelsch U; Bauer S; Doebis C; Thomas S; Unterwalder N; von Baehr V; Reinke P; Knops M; Hanitsch LG; Meisel C; Volk HD; Scheibenbogen C
PLoS One; 2014; 9(1):e85387. PubMed ID: 24454857
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr-virus-encoded LMP2A induces primary epithelial cell migration and invasion: possible role in nasopharyngeal carcinoma metastasis.
Pegtel DM; Subramanian A; Sheen TS; Tsai CH; Golub TR; Thorley-Lawson DA
J Virol; 2005 Dec; 79(24):15430-42. PubMed ID: 16306614
[TBL] [Abstract][Full Text] [Related]
12. Monocytic Myeloid-Derived Suppressor Cells Underpin Resistance to Adoptive T Cell Therapy in Nasopharyngeal Carcinoma.
Hopkins R; Xiang W; Marlier D; Au VB; Ching Q; Wu LX; Guan R; Lee B; Chia WK; Wang WW; Wee J; Ng J; Cheong R; Han S; Chu A; Chee CL; Shuen T; Podinger M; Lezhava A; Toh HC; Connolly JE
Mol Ther; 2021 Feb; 29(2):734-743. PubMed ID: 33038324
[TBL] [Abstract][Full Text] [Related]
13. DNA immunotherapy targeting BARF1 induces potent anti-tumor responses against Epstein-Barr-virus-associated carcinomas.
Zhu X; Perales-Puchalt A; Wojtak K; Xu Z; Yun K; Bhojnagarwala PS; Bordoloi D; Park DH; Liaw K; Bah MA; Lieberman PM; Gary EN; Patel A; Weiner DB
Mol Ther Oncolytics; 2022 Mar; 24():218-229. PubMed ID: 35071745
[TBL] [Abstract][Full Text] [Related]
14. The Association of EBV and HHV-6 Viral Load with Different NK and CD8
Salehi Z; Beheshti M; Nomanpour B; Khosravani P; Naseri M; Sahraian MA; Izad M
Cell J; 2021 Nov; 23(6):626-632. PubMed ID: 34939755
[TBL] [Abstract][Full Text] [Related]
15. Constitutive Interleukin-7 Cytokine Signaling Enhances the Persistence of Epstein-Barr Virus-Specific T-Cells.
Sharma S; Sauer T; Omer BA; Shum T; Rollins LA; Rooney CM
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958791
[TBL] [Abstract][Full Text] [Related]
16. Immune cell phenotype and function patterns across the life course in individuals from rural Uganda.
Nalwoga A; Nakibuule M; Roshan R; Kwizera Mbonye M; Miley W; Whitby D; Newton R; Rochford R; Cose S
Front Immunol; 2024; 15():1356635. PubMed ID: 38562926
[TBL] [Abstract][Full Text] [Related]
17. Roles of Inflammasomes in Epstein-Barr Virus-Associated Nasopharyngeal Cancer.
Looi CK; Hii LW; Chung FF; Mai CW; Lim WM; Leong CO
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33918087
[TBL] [Abstract][Full Text] [Related]
18. Immune surveillance of nasopharyngeal carcinoma (NpC).
Oluwadara O; Barkhordarian A; Giacomelli L; Brant X; Chiappelli F
Bioinformation; 2011; 7(5):271-5. PubMed ID: 22125397
[TBL] [Abstract][Full Text] [Related]
19. Clinical, Epidemiological, Morphological, and Immunohistochemical Aspects of Nasopharyngeal Carcinoma-4-Year Retrospective Study in the Western Part of Romania.
Marin MA; Closca RM; Marin A; Rakitovan M; Nicoara A; Poenaru M; Militaru M; Baderca F
Diagnostics (Basel); 2024 Mar; 14(7):. PubMed ID: 38611634
[TBL] [Abstract][Full Text] [Related]
20. Immune Escape by Non-coding RNAs of the Epstein Barr Virus.
Münz C
Front Microbiol; 2021; 12():657387. PubMed ID: 34234755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
